Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05602805
Other study ID # 2023-3886, 22254
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 15, 2022
Est. completion date November 2072

Study information

Verified date May 2023
Source Laval University
Contact Sylvain Iceta, MD, PhD
Phone +1 (418) 656-8711
Email equipe.iceta@criucpq.ulaval.ca
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Multimorbidity, the co-occurrence of several chronic conditions, is a growing phenomenon that poses new challenges for clinicians and researchers. The association between a mental health disorder and a physical health disorder represents a particularly frequent subtype of multimorbidity and is associated with greater severity and higher consumption of care. It is essential and urgent to explore the specific pathophysiology of this subtype of multimorbidity in order to develop adapted therapeutic strategies. Psychiatric disorders, such as mood disorders, anxiety disorders, attention deficit disorder and binge eating disorder, are common in people with obesity. For example, although most of these disorders may improve after bariatric surgery, some components of these disorders, such as emotional dysregulation and impulsivity, need to be addressed as they appear to be involved in the development of addiction and suicidality after bariatric surgery. Therefore, screening and vigilance of these risks appear increasingly necessary. To address this challenge, the BariaPsy databank aims to explore the screening of certain mental health disorders frequently observed in adults with obesity through an innovative approach that explores behaviors in the form of dimensions. It will help clinicians to quickly identify markers of certain disorders, thus helping them to further investigate the problem and provide personalized resources to their patient.


Description:

The specific research objectives pursued by BariaPsy are as follows: 1. To develop a comprehensive screening tool to support the health professionals (surgeon, physician, specialized practice nurse) in their consultation regarding the mental health of the candidate for overweight or obesity management, helping them to delve deeper into the problem and to give personalized resources to their patient so that they can be well supported. 2. To evaluate the interest of such an evaluation device on the effectiveness and tolerance of the management proposed to the participants. 3. To better characterize patients with physical-mental multimorbidity and the impact of this phenotype on management, in order to issue appropriate recommendations. 4. To identify the prevalence of psychiatric disorders, including mood disorders, anxiety disorders, attention deficit disorder, and binge eating disorder, in the hospital setting, in the overweight/obese population. 5. To identify potential pathophysiological mechanisms to explain the links between mental health and obesity by relating the affected psychological dimensions to the anthropometric, metabolic and sociodemographic parameters of the participants (through information contained in the medical records). 6. Identify potential pathophysiological mechanisms to explain the links between mental health and obesity by relating the affected psychological dimensions to the parameters of current biology available in the medical record (liver, inflammatory, carbohydrate and lipid balance, etc.), but also biological and histological parameters (e.g., adipose tissue samples) in relation to the biobank or management frameworks that are already in place (e.g., in the bariatric surgery service). Also, the participant's authorization will be requested in the Information and Consent Form to have access to their IUCPQ medical record, which contains a collection of sociodemographic, anthropometric and biological information as well as information related to their obesity management (data collection by the bariatric surgery program nurse and/or data collection carried out when the questionnaire is sent to the bariatric medicine or psychiatry programs). The BariaPsy databank will improve the screening of certain mental health disorders frequently observed in the context of overweight or obesity in adults. The data collected will be used for several research studies with the objective of better characterizing patients with physical-mental multimorbidity and the impact of this phenotype on management, in order to issue appropriate recommendations.


Recruitment information / eligibility

Status Recruiting
Enrollment 10000
Est. completion date November 2072
Est. primary completion date November 2067
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Be a patient referred to the IUCPQ for management of overweight or obesity - Have a body mass index (BMI) =25 kg/m2 - Be 18 years old or older Exclusion Criteria: - Be an incapacitated or protected adult as defined by law - Not registered or eligible for RAMQ

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Canada IUCPQ Québec

Sponsors (1)

Lead Sponsor Collaborator
Laval University

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Binge Eating Disorder (BEDS-7) A screening tool that has been designed to screen adults who may have binge eating disorder.
The results indicate whether or not the test screens for binge eating behaviors (yes or no).
Baseline
Primary Binge Eating Scale (BES) To assess the presence of certain binge eating behaviors that may be indicative of an eating disorder.
The higher the score, the more binge eating behaviors is observed. The minimum score is 0 while the maximum score is 46. The final result allows to say if the person has an absent (less than 17), moderate (between 18 and 26) or severe (more than 27) binging level.
Baseline
Primary Generalized Anxiety Disorder (GAD-7) A screening tool and severity measure for generalised anxiety disorder.
The higher the score, the higher the level of anxiety. The minimum score is 0 and the maximum score is 21. The clinically significant score is 15.
Baseline
Primary Patient Health Questionnaire (PHQ-9) The PHQ-9 is a multipurpose instrument for screening, monitoring and measuring the severity of depression.
The higher the score, the more depressive symptoms are present. The minimum score is 0 and the maximum score is 27. It allows to evaluate if there is no depression (9 and less), a major depression (between 10 and 19) or a severe major depression (20 and more).
Baseline
Primary Adult ADHD Self-Report Scale (ASRS-5) To evaluate the manifestations and behaviors of attention deficit and hyperactivity disorder in adults.
The higher the final score, the more evidence of ADHD is present. The minimum score is 6 and the maximum score is 30.
Baseline
Primary Modified Yale Food Addiction Scale 2.0 (mYFAS 2.0) The mYFAS 2.0 was designed to assess food addiction using a shorter version than the YFAS 2.0.It assesses the symptoms of food addiction and the resulting distress and impaired functioning.
The higher the level of symptoms, the more severe the food addiction. Impaired functioning and distress are scored from 0 to 2. Symptoms are scored from 0 to 11. If the functioning and distress score is 1 and above, the food addiction may be mild (2-3 symptoms), moderate (4-5 symptoms), or severe (6+ symptoms).
Baseline
Primary Impulsive Behavior Scale Short Form (UPPS-P) Measurement of factors that can lead to impulsive behavior. There are five subscales: Positive Urgency, Negative Urgency, Lack of Premeditation, Lack of Perseverance, and Sensation Seeking.
A higher score on the scale or subscale corresponds to a higher level of impulsivity. The minimum total score is 1 and the maximum total score is 4.
Baseline
Secondary Gender identity Choose from: Cisgender, Transgender, non-binary, Queer, I refuse to answer, Other Baseline (Sociodemographic Questionnaire)
Secondary Ethnic origin Choose from: Black, East Asian, Latino, Middle Eastern, South Asian, Southeast Asian, South Asian descent, White, I refuse to answer, Other Baseline (Sociodemographic Questionnaire)
Secondary Marital status Choose from: Single, Common-law, Married, Divorced, Widowed, I refuse to answer, Other Baseline (Sociodemographic Questionnaire)
Secondary Highest level of education Choose from: None, High School, Cegep, Diploma of Vocational Studies, Vocational Technical, Undergraduate University, Graduate University, Postgraduate University or Other Baseline (Sociodemographic Questionnaire)
Secondary Average annual income In dollars. Baseline (Sociodemographic Questionnaire)
Secondary Living space for most of the year Choose from: House/apartment/condominium, apartment or condominium for seniors, home of a relative or friend, retirement home, adult foster home, CHSLD, other Baseline (Sociodemographic Questionnaire)
Secondary Current employment status Choose from: working full time, working part time, unemployed or laid off looking for work, unemployed not looking for work, homemaker, student, retired, disable Baseline (Sociodemographic Questionnaire)
Secondary Number of person living at your place of residence Choose from: living alone, 1 person, 2 persons, 3 persons, 4 persons, 5 persons or more Baseline (Sociodemographic Questionnaire)
Secondary Weight In kilograms (kg). Baseline (Sociodemographic Questionnaire)
Secondary Height In meters (m). Baseline (Sociodemographic Questionnaire)
Secondary Food allergies or intolerances Open answer Baseline (Bariatric Surgery Initial Assessment)
Secondary Lifestyle habits Choice: tobacco products, electronic cigarettes (with or without nicotine), alcohol and/or drugs.
Quantity, frequency and cessation date, if applicable, are requested.
Baseline (Bariatric Surgery Initial Assessment)
Secondary Health history and conditions Choice: Type 1 or 2 diabetes, hypothyroidism, hyperthyroidism, thyroid nodules, cirrhosis, inflammatory bowel disease, recent prior digestive investigation (less than 5 years), colonoscopy, abdominal surgery, bariatric surgery, other surgery, asthma, COPD, home oxygen, sleep apnea, menstruation (hysterectomy, hormone therapy, pills or IUD), coronary angioplasty (with or without stent), myocardial infarction, cardiac surgery, thrombophlebitis, coagulopathy, pulmonary embolism, renal lithiasis, CKD, psychiatric hospitalization, suicide attempt, mental health diagnosis, eating disorders, neoplasia, chronic pain, other health conditions
If applicable, since when and followed by whom.
Baseline (Bariatric Surgery Initial Assessment)
Secondary Family history of bariatric surgery Open-ended questions about obesity and bariatric surgeries in the applicant's family. Baseline (Bariatric Surgery Initial Assessment)
Secondary Weight and diet history Open-ended questions about current and past weight and dieting to get a sense of the person's history over time in relation to their weight. Baseline (Bariatric Surgery Initial Assessment)
Secondary Food history Open-ended questions related to meal intake, meal frequency, food consumed and food-related behaviors. Baseline (Bariatric Surgery Initial Assessment)
Secondary Physical activity History Open-ended questions about physical activity, which ones are practiced, how often and what barriers are encountered. Baseline (Bariatric Surgery Initial Assessment)
Secondary Perception of body image Open-ended questions about body image and motivation to treat obesity. Baseline (Bariatric Surgery Initial Assessment)
Secondary Expectations of health care professionals Open-ended response to know the expectations towards health professionals in the management of their obesity. Baseline (Bariatric Surgery Initial Assessment)
Secondary Motivation to have surgery Since when does he want to have surgery and for what reasons? Baseline (Bariatric Surgery Initial Assessment)
Secondary Nutritional recommendations Three recommendations personally issued by a nutritionist are requested. Baseline (Bariatric Surgery Initial Assessment)
Secondary Knowledge of bariatric surgery Open-ended questions about the different resources that should have been consulted as well as the knowledge required (side effects, recommendations, complication and percentage of failure) are asked. Baseline (Bariatric Surgery Initial Assessment)
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2